Harout Semerjian News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harout semerjian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harout Semerjian Today - Breaking & Trending Today

GlycoMimetics fails phase 3 blood cancer trial, sinking stock

GlycoMimetics fails phase 3 blood cancer trial, sinking stock
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Harout Semerjian , National Cancer Institute , Big Pharma , Cancer Institute ,

GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Study of uproleselan combined with chemotherapy did not meet its primary endpoint of overall survival in the intent to treat population

Adverse events were consistent with known side effect. ....

United States , Harout Semerjian , Drug Administration , Alliance For Clinical Trials In Oncology , Exchange Commission , Glycomimetics Inc , Chinese National Medical Products Administration , Chief Executive Officer , Clinical Trials , First Quarter , Breakthrough Therapy , Fast Track , Bone Marrow , Biohealth Capital , Annual Report ,

Uproleselan Plus Chemotherapy Misses Phase 3 Trial OS End Point in R/R AML

Uproleselan plus chemotherapy did not achieve a statistically significant improvement in OS vs chemotherapy alone in patients with relapsed/refractory AML.

....

United States , Harout Semerjian , Chinese National Medical Products Administration , National Cancer Institute , Alliance For Clinical Trials In Oncology , Clinical Trials , Hematologic Oncology , Acute Myeloid Leukemia ,

GlycoMimetics, Inc. (NASDAQ:GLYC) Q4 2023 Earnings Call Transcript

Operator: Good morning, and thank you for joining the GlycoMimetics Q4 and Full Year 2023 Earnings Call. At this time, all participants are in a listen-only mode. ....

United States , Tara Bancroft , Christian Dinneen , Bruce Johnson , Brian Hahn , Harout Semerjian , Naureen Quibria , Children Oncology Group Phase , Company Counsel At Glycomimetics , Glycomimetics Inc , Pediatric Early Phase Clinical Trial Network , Dana Farber Cancer Institute , American Cancer Society , National Cancer Institute , Alliance For Clinical Trials In Oncology , American Society Of Hematology Research Collaborative , Call Transcript March , Full Year , Christian Dinneen Long , Company Counsel , Chief Executive Officer , Chief Financial Officer , Edwin Rock , Chief Medical Officer , Chief Commercial , Clinical Trials ,

GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023

GlycoMimetics Reports Highlights and Financial Results for Fourth Quarter and Full Year 2023
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Harout Semerjian , Shantha Tyavanagimatt , Sickle Cell Disease Research Network , National Cancer Institute , Chinese National Medical Products Administration , Alliance For Clinical Trials In Oncology , Glycomimetics Inc , Exchange Commission , Conference Call , Mimetics Reports Highlights , Financial Results , Fourth Quarter , Full Year , Chief Executive Officer , Clinical Trials , Sickle Cell Disease Research , Senior Vice President , Breakthrough Therapy , Fast Track , Biohealth Capital , Annual Report ,